Clinical trial
MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel…
NCT00237653 · University Hospital, Grenoble, Other · Terminated
Key facts
| NCT number | NCT00237653 |
|---|---|
| Title | MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus |
| Official title | Relevance of Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus |
| Lead sponsor | University Hospital, Grenoble, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cytomegalovirus Infections, Inflammatory Bowel Diseases |
| Intervention type | Drug |
| Interventions | Valganciclovir |
| Enrollment | 40 |
| Start date | Feb 1, 2004 |
| Completion | Dec 1, 2007 |
| First posted | Oct 12, 2005 |
| Last update posted | Apr 3, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: